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A Methodology for Anatomic
Ultrasound Image Diagnostic Quality Assessment
Martin Christian Hemmsen, Theis Lange, Andreas Hjelm Brandt,
Michael Bachmann Nielsen and Jørgen Arendt Jensen
Abstract—This paper discusses methods for assessment of ul-
trasound image quality based on our experiences with evaluating
new methods for anatomic imaging. It presents a methodology
to ensure a fair assessment between competing imaging methods
using clinically relevant evaluations. The methodology is valuable
in the continuing process of method optimization and guided
development of new imaging methods. It includes a three phased
study plan covering from initial prototype development to clinical
assessment. Recommendations to the clinical assessment protocol,
software, and statistical analysis are presented. Earlier uses of the
methodology has shown that it ensures validity of the assessment,
as it separates the influences between developer, investigator, and
assessor once a research protocol has been established. This
separation reduces confounding influences on the result from
the developer to properly reveal the clinical value. The paper
exemplifies the methodology using recent studies of Synthetic
Aperture Sequential Beamforming tissue harmonic imaging.
I. INTRODUCTION
NEW and improved imaging schemes are continuouslybeing introduced in medical ultrasound for visualizing
the anatomy. This includes improved B-mode schemes like
non-linear imaging [1], synthetic aperture imaging [2], [3] and
the derived method synthetic aperture sequential beamforming
(SASB) [4], plane wave imaging [5], and minimum variance
beamforming [6], [7]. Often these methods claim to improve
on image quality with an underlying assumption that this trans-
lates into better diagnostic accuracy. To substantiate this claim,
the new imaging method should be realistically compared to
current imaging system in a clinical setting. The purpose of
this paper is to give a fairly general approach to evaluating
new imaging schemes for visualizing the anatomy based
on our experiences with evaluating new synthetic aperture
(SA) methods. Parts of the approach can also be used for
investigations of e.g. flow imaging as performed in [8].
There are several tasks, which involve assessment of image
quality. Equipment purchasing is partly based on performance
specifications, acceptance testing verifies that the system ful-
fills the specified performance, quality assurance is used to
ensure a constant system performance, clinical testing con-
centrates on the fulfillment of clinical needs, and optimization
attempts to find best ways to use the imaging system for
clinical purposes. These different tasks are best performed
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by different assessment methods, and the outcome is often
referred to as technical (or physical) image quality or clinical
image quality.
The term technical image quality is devoted to the di-
rect measurable aspects of the image, and has for a long
time mainly been focusing on spatial resolution, contrast,
penetration depth, and uniformity. [9]–[15]. Historically in
particular the spatial resolution has been used to characterize
the imaging performance. However, this imaging performance
metric can be misleading, and it is well recognized that the
Rayleigh resolution or full-width-at-half-maximum (FWHM)
criterion can not stand alone. Recommendations for measuring
the comparative performance of medical ultrasound imaging
equipment includes determination of the visibility of voids
in a continuous background [16]–[18]. Imaging phantoms,
however, does not provide a way to theoretically assess the
performance of different hypothetical imaging systems. Al-
though repeated image simulations can be performed to assess
a wide variety of system parameters, this approach is very
computationally challenging. Cystic resolution, a performance
metric, conceptually related to the void-visibility, were sug-
gested to help predicting the performance of new methods
[19], [20]. It quantifies performance as the size of a void that
produce a given contrast. The metric is useful in that it enables
a straightforward optimization of parameters that affects image
quality.
Researchers of ultrasound imaging methods are interested
in assessing the quality of their methods to increase its per-
formance and clinical usefulness. When new imaging methods
are developed they are often favorably evaluated by phantom
setups against a reference method. The evaluations often leave
the question of method optimization open, and as a conse-
quence, often conclude that the novel method is favorable.
However, this is a far too wide conclusion as the developer is
not separated from the investigator. The value of the evaluation
is further questionably, because despite a massive effort by
several groups, there is no international consensus about a
complete protocol for technical image quality assessment.
Furthermore, establishing the link between physical image
quality measures and clinical utility has been pursued for
decades, yet the relationship between the results of technical
performance and clinical usability is not fully understood.
When one speaks of clinical image quality, the actual point
of view and the definition of image quality are often left un-
specified. In medical ultrasound, images are used to diagnose
patients (diagnostic imaging) or to treat them (interventional
imaging). Therefore, image quality is most meaningfully de-
0885-3010 (c) 2016 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission. See http://www.ieee.org/publications_standards/publications/rights/index.html for more information.
This article has been accepted for publication in a future issue of this journal, but has not been fully edited. Content may change prior to final publication. Citation information: DOI 10.1109/TUFFC.2016.2639071, IEEE
Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
HEMMSEN ET AL: METHODOLOGY 2
fined through the use of the images in accomplishing these
tasks.
Clinicians and policymakers often distinguish between the
efficacy and the effectiveness of an intervention. Efficacy
trials (explanatory trials) determine whether an intervention
produces the expected result under ideal circumstances. Ef-
fectiveness trials (pragmatic trials) measure the degree of
beneficial effect under real world clinical settings [21].
Fryback and Thornbury [22] presented a general six-tiered
hierarchical model, which extends from basic laws of physics
of imaging, through clinical use in decisions about diagnosis
and intervention, to patient outcome and societal issues. The
model can be used to classify assessment studies and provides
a structure in which to relate efficacy to technology assessment
and outcome research [23]. For an imaging examination to be
efficacious at a higher level, it must be efficacious at lower
levels; however, the reverse is not necessarily true. Increase
in efficacy at lower level (e.g., improved imaging technical
quality, level 1) does not guarantee improvement in efficacy
at a higher level. The model is interesting, because it helps
understand the importance of assessing the image quality at
different levels.
The purpose of this paper is to disseminate best practices in
relation to the assessment of image quality for new ultrasound
imaging methods based on our experience of such assessment
in a number of studies [24]–[26]. We have here been con-
fronted by the many choices in making a fair comparison
and ensure a statistically valid result. The paper presents a
methodology that will potentially ensure a fair assessment
between competing imaging methods, and is described in
Section III. The methodology is inspired by the six-tiered
hierarchical model and selected levels of the model is ex-
plained in Section II. The methodology suggests a three phased
study plan covering the levels from technical assessment in
the early prototype development phase, to the first initial pre-
clinical trial and finally a clinical trial assessing the diagnostic
accuracy and diagnostic thinking during the second and third
phase. Based on recommendation 500 from the International
Telecommunication Union - Radio-communication (ITU-R)
for subjective quality assessment [27], a clinical assessment
protocol and software is developed and presented in Section
IV, and Section V presents the statistical analysis. The method-
ology is exemplified using a recent study of Synthetic Aperture
Sequential Beamforming harmonic imaging.
II. A HIERARCHICAL MODEL OF EFFICACY
The hierarchical model is useful in discriminating between
different levels of efficacy [22]; Table I gives a short overview.
The following sections will go into more details about the first
three levels. These levels are the relevant levels in relation to
method optimization and guided development of new methods.
A. Technical Efficacy
At the foundation of the hierarchy is assessment of technical
efficacy: studies that are designed to determine if a particu-
lar proposed imaging method has the underlying ability to
produce an image that contains useful information. Technical
TABLE I
HIERARCHICAL MODEL a
Technical efficacy: production of an image or information
Measures: signal-to-noise ratio, resolution, contrast, penetration, etc.
Diagnostic accuracy efficacy: ability to differentiate between disease
and nondisease.
Measures: sensitivity, specificity, receive operator characteristic curves.
Diagnostic thinking efficacy: impact on likelihood of diagnosis.
Measures: diagnostic certainty.
Treatment efficacy: potential to change therapy for a patient
Measures: treatment plan, operative or medical treatment frequency.
Outcome efficacy: effect on patient health
Measures: mortality, quality-adjusted life years, health status.
Societal efficacy: appropriateness from perspective of society.
Measures: cost-effectiveness.
aadapted from [28].
efficacy is generally the purview of developers concerned
with the physical parameters. These include spatial resolu-
tion, contrast-to-noise ratio, signal-to-noise ratio, clutter-to-
tissue ratio, speckle signal-to-noise ratio, uniformity, cystic
resolution [19], [20], penetration depth, contrast detectability
[29] among others. These parameters are usually derived
under optimal laboratory conditions and only quantifies part of
the image quality. Additional important variables include the
presence of artifacts from the imaging itself. Determination
of the technical efficacy is a prerequisite for consideration of
efficacy at subsequent levels.
B. Diagnostic-Accuracy Efficacy
The second level in the hierarchy determines if the imaging
method predicts the truth. The study of accuracy is character-
ized by the attempt to measure performance for the purpose
of making diagnoses and requires interpretation of an image
by an observer. To determine the diagnostic-accuracy the true
disease status of every subject is assumed to be known with
certainty, either by an existing gold standard for indication of
presence of such a disease/abnormality or by an independent
assessment. Simple measures such as counting the number
of abnormal patients found in a case series, sensitivity, and
specificity are often used, but more sophisticated concepts of
test performance, such as the receiver operating characteristic
(ROC), are becoming more prevalent.
Receiver operating characteristic analysis has become a
favored method for reflecting diagnostic accuracy [30]–[33],
although there are acknowledged problems of spectrum bias
in control patients [34], and problems of establishing the
true (or gold standard) diagnosis [35]. In an ROC experiment
each evaluated image or movie is assigned a rating, and by
convention a higher rating indicates greater evidence of the
presence of an abnormality.
Important to all measures of diagnostic-accuracy are that
they attempt to measure performance of the imaging for the
purpose of making diagnoses, and that they all require inter-
pretation of the image by an observer, such as a radiologist. As
such, diagnostic accuracy is the result from the joint function
of image technical quality and interpretation by a observer.
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Another important aspect to consider is that diagnostic
accuracy is also a function of the physician requesting the
examination, because the physician selects which patients will
be imaged. As sensitivity and specificity can vary, depending
on the spectrum of patients selected for imaging, this selection
process can affect the result. Design of the clinical research,
thus, requires a detailed study protocol to ensure both internal-
and external validity [36].
C. Diagnostic-Thinking Efficacy
Image information may change the physicians diagnostic
certainty, change the differential diagnosis, strengthen a com-
peting diagnostic hypothesis, or simply reassure the physician
that no occult and unexpected is present. As such, at the third
level the effect on the physicians certainty of a given diagnosis
is evaluated.
The assessment of diagnostic thinking efficacy is relevant;
because if the level of image quality is extremely low, the
image provides little information for the diagnosis, and di-
agnostic accuracy is poor. When the image quality improves,
important patterns become recognizable and diagnostic per-
formance improves. But beyond a certain level, where the
important features are already visible, and no additional image
information that would be useful for the radiologist can be
brought in the image, the diagnostic thinking performance
will saturate. As such, even if there is a difference between
methods in diagnostic-accuracy, they can provide the same
level of diagnostic thinking efficacy.
Assessment of the diagnostic thinking efficacy requires no
ground truth and can be measured by, for example, the differ-
ence in the clinician’s certainty of a diagnose. For competing
imaging methods one can measure whether the physician has
relative greater or less confidence in the diagnosis using the
new method.
III. METHODOLOGY
The main issue in performing a structured and fair com-
parison between imaging methods, is to keep factors, such
as transducer, scanner, region of interest, frame rate, and
recording time constant. Other issues to consider is to get
sufficient number of scans under realistic operating conditions
and separating the developer and assessor in the evaluation
process to remove personal bias. To fulfill these demands we
propose that evaluations of new methods is conducted in a
three stage research, as illustrated in Fig. 1:
The suggested methodology describes the research steps
and experiments needed in an attempt to establish evidence
of image quality differences between competing methods for
ultrasound images depicting the anatomy. The methodology
encompasses three phases, from demonstration of prototype to
clinical assessment. The process of assessing a new method
is beneficially split into three phases to allow a clear commu-
nicative process and to set focus on the different activities
through the process. The three phases are performed in a
sequential order, and if the assessment in one phase does not
show evidence of improved image quality the following phases
are skipped. The first phase is iterative in nature, and once a
Fig. 1. Diagram of the methodology. Phase I relates to the demonstration
of a prototype. Phase II relates to the exploratory investigation of the first
trials conducted in accordance with the official standards (FDA or IEC) and
approved by the local ethics committee. Phase III relates to the clinical trial
that generates data on efficacy in a controlled clinical setting.
set of optimal parameters are determined, the setup is fixed
and the next trial stage is begun.
A. Phase I: Demonstration of prototype
In this stage the developers demonstrate a workable pro-
totype of the new imaging method with measurements on
phantoms and a few in-vivo images. In a collaboration between
the developer and ultrasound specialist, the new method’s
parameters are iteratively optimized to achieve the best pos-
sible setup. During the iterative process the technical efficacy
is assessed. This demands that the method is at a stage of
development, where the optimal set of parameters can be
fixed during the investigation and tuning in Stage 1. The
ultrasound specialist is allowed to change a defined set of
imaging parameters during the scan to optimize image scans
during all stages, and should be trained to perform this during
Stage 1.
Assessment of technical efficacy is concerned with the
physical parameters describing technical image quality. These
are typically first estimated using simulation software such
as Field II [37], [38] and determination of the point-spread-
function (PSF) for linear imaging systems. For non-linear
imaging more complicated simulation schemes like K-wave
[39], Abersim [40], finite element methods [41], or a non-
linear angular spectrum approach [42] can be used to also
include effects distorting the PSF. Using the PSF the spatial
resolution and cystic resolution [19], [20] are determined and
used to optimize the method for a chosen clinical useful
scenario. The parameters are usually derived under optimal
conditions and needs to be validated using measurements
on phantoms [10]. Once a suitable setup is determined and
validated, the technical performance can be compared with
that of a reference method. The reference method must be
optimized with same care as the new method. Ideally the
reference method is optimized by an independent and blinded
developer or manufacturer determined parameters are used.
A technical assessment in favor of the new method is a
prerequisites for a consideration of assessment of efficacy at
a higher level.
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Before starting the clinical trials, measures are conducted to
adjust the transmit levels such that intensities and temperature
constraints are obeyed [43]–[46]. Once parameters of the two
competing methods are fixed, a few in-vivo measurements
are obtained to study the preliminary efficacy. Such tests
compliments the technical assessment to decide whether the
new method has scientific merit for further development and
assessment. Furthermore, the in-vivo images helps the devel-
oper to decide which questions to answer using the clinical
study.
B. Phase II: Pre-clinical study
Phase II relates to the exploratory investigation of the first
trials conducted in accordance with the United States Food
and Drug Administration (FDA) or similar standards in other
countries and approved by the local ethics committee. These
trials are designed to establish early on whether the method
behaves in human subjects as was expected from the prototype
development. Typically the relevance of a clinical investigation
is tested in a small group of people. It should be emphasized
that pre-clinical here denotes a small trial on human volunteers
prior to the real clinical trial, and is not a pre-clinical trial on
animals.
The phase begins with the development of a clinical proto-
col [36]. The protocol describes carefully the planning and
execution of the trial with clear objectives. The developed
protocol describes the methods and its parameters in such
a degree that the developer is and should be left out in
the active part of the following research and should not
have any influence on the outcome of the research in either
data acquisition, any form of processing of it, or evaluation.
The outcome of the trial is primarily the determination of
feasibility, time requirement and cost of recruiting adequate
numbers of eligible participants. The trial is also designed
to demonstrate that planned measurements, data collection
instruments and data management systems are feasible and
efficient.
At this phase of the research it is important to be concise
about which questions the developer wants to answer using
the clinical trial. Also, the selection of test persons have an
influence on the outcome of the clinical study. It is important
to select representative test persons, such that the validity of
the research questions are ensured. A key question is also to
determine here how to present the data and how the assessor is
educated to use the evaluation program. This phase ends when
the outcome of the trial has been evaluated. If the outcome of
the evaluation finds it feasible to conduct the clinical trial with
the estimated number of participants (power calculation) and
the equipment described in the clinical protocol, the clinical
trial begins.
C. Phase III: Clinical study
Clinical trials generate data on efficacy in a controlled
clinical setting. When a study assesses efficacy, it is looking
at whether the method is able to influence an outcome of
interest (e.g. detection rate or diagnostic certainty) in the
chosen population. At this stage of research the statistical
significance of the new method is investigated by comparison
to a reference method. Assessment of the method is performed
by a number of ultrasound specialists independent to the
method. Furthermore, the assessors must be separated from the
specialists performing the ultrasound scanning, blinding them
from the acquisition and any form of processing of it. The
study is performed on a large enough group of subjects to test
the hypothesis. The number of required subjects is determined
in Phase II during the power calculation.
IV. ASSESSMENT METHODOLOGY
To date there exist no published methods that objectively
assesses the clinical quality and efficacy of ultrasound images,
and it is probably unlikely that a general, objective metric
for this can be found, and as a consequence clinical image
quality is assessed subjectively. One major limitation with
subjective assessment is, if the opinion is just based on an
impression of quality, the usefulness of the assessment is
questionable. When judged by task-based criteria - for example
by the opinion of the radiologist relating to his/her ability to
recognize certain anatomical details or features in the image
(diagnostic-accuracy) or his/her confidence on the perception
of these details (diagnostic-thinking), the assessment is more
relevant.
The proposed assessment methodology is based on earlier
publications of studies of clinical evaluation between pairs of
sequences [24]–[26] and suggested testing procedures accord-
ing to recommendation 500 from ITU-R [27] for subjective
quality assessment. The proposed methodology describes two
assessment situations, one for the assessment of diagnostic-
accuracy and one for diagnostic-thinking. A detailed descrip-
tion of a software toolbox to help in the assessment can be
found in [47].
Assessors should be an expert observer, i.e. an observer
that has expertise in the field of study and on image artifacts.
Assessors should not be, or have been, directly involved, in
the development of the system under study. The number of
assessors needed depends upon the sensitivity and reliability
of the test procedure and upon the anticipated size of the effect
sought. This is similar in spirit to the power analysis preceding
any Randomized Controlled Trial (RCT). In our setting there
are, however, many more assumptions to be made before such
a power analysis can be conducted. As a rule-of-thumb based
on our studies we therefore suggest to use three assessors and
10 patients in Phase II. The Phase III design should be roughly
double size in terms of assessors and patients per assessor
depending on the efficacy found in phase II. If the study is very
large or invasive we suggest to include a trained statistician to
conduct a more formal sample size calculation.
Assessors should be carefully introduced to the method
of assessment, the types of stimuli, the grading scale, the
sequence, and timing. Training sequences demonstrating the
range and the type of the stimuli to be assessed should be
demonstrated in an introductory material, where the assessor
is allowed to ask question to fully understand the task at hand.
A test session, see Fig. 2, should at most last up to one
hour, and should be conducted in a darkened room. If the
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assessor is not completed within one hour, a 15 min break is
forced before continuing the assessment to minimize effects
from tiredness. At the beginning of the first session, about five
representative presentations should be introduced to stabilize
the assessors opinion and expectations. The data issued from
these presentations must not be taken into account in the
results of the test. A random order should be used for both
the introductory presentations and the final test. It is important
that the sequence is arranged, so that any effects of tiredness
or adaptation are balanced out from session to session.
A test session can either be focused on the assessment of
diagnostic-accuracy or diagnostic-thinking.
Fig. 2. Illustration of a test session. Introductory presentations are used to
stabilize the assessors opinion and expectations. The main part of the test
session is performed directly following the introductory presentations.
A. Diagnostic Accuracy
The presentation method for assessment of diagnostic ac-
curacy combines elements of the double stimulus continuous
quality scale (DSCQS) method (ITU BT.500-11, Section 5)
and the non-categorical judgment methods (ITU BT.500-11,
Section 6.1.4.3). For reference, it may be called the sequential
stimulus absolute scale (SSAS) method.
A test session comprises a number of presentations, each
with a single observer. Unlike the DSCQS method where the
assessor only observes the stimulus two times and rates each
stimuli, the assessor is free to observe the stimuli until a
decision is obtained.
Fig. 3a shows a basic test cell illustrating the presentation
structure of reference and test material. Reference and test
movies or images are displayed in a unique randomized
sequential order. For movies, stimuli are visualized in a
palindromic display fashion (looping forth and back). Fig. 3b
shows the associated rating scale.
Fig. 3b illustrates the suggested rating scale. The scale is
based on the non-categorical judgment method as described
in ITU BT.500-11, Section 6.1.4.3. The judgment scale used
is a numerical scale, where assessors assign a value to each
stimuli that reflect the assessors certainty of abnormality. As
such, the range of values are restricted to 0 to 100.
Test sessions consists of a series of test cells. These should
be presented randomized, blinded, and independently of each
other and, preferably, in a different random sequence for each
observer. Table II illustrates the required stimuli for each test
cell. Preferably, there would be at least 2 repetitions of each
of the test cells to check for consistency.
Assessors are instructed to rate on a scale from 0 to 100%
how certain they are that the stimuli contains an abnormality?
They assess the sequence by placing a bar at the respective
(a)
(b)
Fig. 3. Assessment of diagnostic-accuracy. (a) Basic test cell illustrating the
presentation structure of reference and test material. Reference and test movies
are displayed individual in randomized order. Here the reference stimuli is
shown during time A and the stimuli from the new method is shown during
time B. Assessors are free to observe the stimuli until a mental measure of
certainty is obtained. (b) The rating scale used to quantify the certainty.
TABLE II
DESCRIPTION OF THE TEST CELL FOR ASSESSMENT OF
DIAGNOSTIC-ACCURACY
Stimuli
Reference sequence
Test sequence
rating. Figure 4 illustrates the GUI associated with the rating
process of diagnostic-accuracy.
Fig. 4. Illustration of the GUI associated with the assessment of diagnostic-
accuracy. The bar is placed at the respective rating where the assessor score
their level of certainty that the stimuli contains an abnormality.
B. Diagnostic Thinking
The presentation method for assessment of diagnostic cer-
tainty combines elements of the simultaneous double stimulus
for continuous evaluation (SDSCE) method (ITU BT.500-11,
Section 6.4) and the double stimulus continuous quality scale
(DSCQS) method (ITU BT.500-11, Section 5). For reference,
it may be called the simultaneous stimulus relative quality
scale (SSRQS) method.
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As with the SDSCE method, each trial will involve a split-
screen presentation of material from two stimuli. One of the
stimuli will be the reference, while the other is the test.
The reference could be a conventional setup or the setup to
compare against, and the test is the method under investigation.
Unlike the SDSCE method, observers will be unaware of the
scanner conditions represented by the two members of the
stimuli pair and the left-right placements are randomized.
As with the DSCQS method, a test session comprises a
number of presentations, each with a single observer. Unlike
the DSCQS method, where the assessor only observes the
stimulus two times and rates each stimuli, the assessor is free
to observe the stimuli until a mental measure of relative quality
associated with the stimulus is obtained. Fig. 5a shows a basic
test cell illustrating the presentation structure of reference
and test material. Reference and test stimuli are displayed as
matching pairs side-by-side with random left-right placement.
Stimuli are visualized in a palindromic (looping forth and
back) display fashion to minimize discontinuity at the joints.
(a)
(b)
Fig. 5. Assessment of diagnostic certainty. (a) Basic test cell illustrating the
presentation structure of reference and test material. Reference and test are
displayed as matching pairs side-by-side with random left-right placement.
Assessors are free to observe the stimuli until a mental measure of relative
quality associated with the stimuli is obtained. (b) Visual analog scale (VAS)
for diagnostic certainty comparison between left and right stimuli.
The most often used criteria for manufacturers to implement
new processing methods in their equipment is better diag-
nostic value compared to the existing method. Accordingly,
a stimulus comparison scale, as described in ITU BT.500-
11, Section 6.2, is recommended to be used. The specific
judgment scale used is a non-categorical (continuous) scale, as
described in ITU BT.500-11, Section 6.2.4.2. For reference it
may be called Visual Analog Scale (VAS). During introduction
of the assessors to the system and the rating methods, VAS
is described with the same number of labels as on the ITU-R
categorical comparison scale, but with slightly modified labels
(much better, better, slightly better, the same, slightly better,
better, much better) to report the existence of perceptible
quality differences and allow the random left-right placement
of the stimuli. After introduction and during assessment the
labels are hidden to avoid categorized data and to get a
smoother distribution. Fig. 5b shows the associated VAS for
diagnostic certainty comparison between left and right stimuli.
Test sessions consists of a series of test cells. These should
be presented randomized, blinded, and independently of each
other and, preferably, in a different random sequence for each
observer. Table III illustrates the required stimuli for each
test cell. Preferably, there would be at least 2 repetitions of
each of the test cells to check for consistency. Note that each
test cell consists of two pairs, the reference stimuli shown to
the left and test stimuli to the right and vice verse. The two
repetitions should not be displayed sequentially in time after
each other, but randomized.
TABLE III
DESCRIPTION OF THE TEST CELL FOR ASSESSMENT OF
DIAGNOSTIC-THINKING.
Left stimuli Right stimuli
Reference sequence Test sequence
Test sequence Reference sequence
The judgment sessions should be divided into sittings not
more than one hour in duration separated by a 15-minute rest
periods. Assessors are instructed to evaluate whether they have
a relative greater or less confidence in the diagnosis using the
new method on a visual analog scale. Note here that it is not
evaluated if the diagnose is correct, but merely if the observer
feels more confident. As such the ground truth does not need
to be known. Fig. 6 illustrates the GUI associated with the
rating process of diagnostic-thinking.
Fig. 6. Illustration of the GUI associated with the rating process of diagnostic
thinking. Two stimuli are shown side-by-side, with the rating bar beneath.
V. STATISTICAL ANALYSIS
The statistical analysis section is split into two sections, one
for each clinical test.
A. Diagnostic Accuracy
Assessing the diagnostic accuracy, assessors are instructed
to rate on a scale from 0 to 100% how certain whey are
that the stimuli contains an abnormality. In this two-class
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prediction problem, the evaluated stimuli is assigned a rating
and by convention a higher rating indicates greater evidence of
the presence of an abnormality. A test is considered positive,
if the rating exceeds a certain threshold c representing the
level of decision point. The agreement between a test and the
true disease status can be summarized using two quantities:
True Positive Ratio (TPR) and False Positive Ratio (FPR).
TPR is equivalent to sensitivity (Number of true positive
assessment)/(Number of all positive assessment) and FPR
is equivalent to 1 − specificity (Number of false positive
assessment)/(Number of all negative assessment).
A ROC curve is the plot of TPF versus FPF , where the
points on the graph are determined as the level of decision
point, c, is varied. Thus, the ROC curve summarizes the
agreement between ratings and the presence of an abnormality
for all thresholds simultaneously. It is thereby simultaneously
a tool to access the overall predictive quality, and a tool to
determine the optimal cut-off point, c.
From [48] the ROC curve can be interpreted such that
the faster the curve approach the upper left corner, the more
useful the test results are. The slope of the tangent line to a
cut-point tells us the ratio of the probability of identifying
true positive over true negative, the likelihood ratio (LR).
LR = sensitivity/(1 − specificity). If the ratio is equal to
1, the selected cut-point does not add additional information
to identify true positive result. If the ratio is greater than 1, the
selected cut-point help identify true positive result. If the ratio
is less than 1, it decreases disease likelihood. The area under
ROC curve (AUC) provides a way to measure the accuracy
of a diagnostic test. The larger area, the more accurate the
diagnostic test is. An area of 1 represents a perfect test; an
area of 0.5 represents a worthless test. AUC can be defined by
the following equation, where f = (1− specificity) = FPR
and ROC(f) is sensitivity,
AUC =
∫ 1
0
ROC(f) df. (1)
As the assessors might use the scales (the 0 to 100 score)
differently a ROC curve with corresponding AUC estimate
should be derived for each assessor and for each method
separately. Standard software such as SPSS (the ROC-curve
option in the Analyze menu) can produce ROC curves and
AUC estimates along with associated standard errors directly
from the provided scores. However, as the two methods and
different assessors are depended (as they are all based on the
same scans) formal statistical comparisons of methods cannot
be straightforwardly done. It is possible to use the test for
the AUC being above 0.5, which is the test for prediction
accuracy above chance. In the next section we introduce a
formal statistical test for the superiority of one method above
the other.
B. Diagnostic-Thinking
Intuitively a positive average VAS score will indicate that
one method is superior to the other. However, due to the
dependence between observations a standard t-test cannot be
employed. Instead the VAS scores should be analyzed by
a mixed effect linear model with a random effect [49] for
each image pair and each assessor, thereby accounting for the
dependence induced by repeatedly scoring the same image pair
and collecting multiple scores from the same assessor. Since
pairs are showed randomly either left or right, we do not have
to take into account a possible preference for the image viewed
on, say, the left side of the screen. Mathematically the mixed-
effect model is given by
yi,j = a0 + αi + βj + i,j , (2)
where yi,j is the VAS score of the j’th assessor and the
i’th scan, βj is a assessor specific random effect, αi is a
scan specific random effect, and i,j is a measurement error. α
and β are assumed to follow potentially correlated mean zero
normal distributions and  an uncorrelated mean zero normal
distribution. If the fixed parameter a0 is significantly different
from zero, there is evidence that one method is preferred. The
model can be fitted in any statistical software package. In SPSS
using the Repeated measures option in the Analyse menu. In R
the nlme-package can be used. Model fit should be assessed by
Q-Q plots [50] of the residuals from the mixed effect model.
VI. EXPERIENCES FROM PREVIOUS STUDIES
The developed methodology has been used in a number of
recent studies of Synthetic Aperture Sequential Beamforming
(SASB). In this section, experiences from using the method-
ology and selected results are shown to demonstrate the use
and work flow.
A. Phase I - Demonstration of prototype
In this phase, parameters such as F#, focus distance,
apodization etc. were optimized using simulation software and
validated using measurements on a phantom with 2 wire tar-
gets. Table IV and Fig. 7 illustrates the result of the technical
performance assessment. Conventional imaging using dynamic
receive focusing (DRF) were chosen as the reference method,
and was already implemented and optimized on an available
commercial scanner (BK Ultrasound, ProFocus). The scanner
allowed data acquisition of the two competing methods in
an interleaved imaging mode, which ensured that data were
acquired from the same anatomical region [47]. Parameters
specified by the commercial manufacturer was used, and this
ensured no conflict of interest during the image optimization.
TABLE IV
RESULT OF THE TECHNICAL PERFORMANCE ASSESSMENT. FROM LEFT:
CYSTIC RESOLUTION, SPATIAL RESOLUTION IN LATERAL DIMENSION,
SPATIAL RESOLUTION IN AXIAL DIMENSION
R12dB FWHMlat FWHMax
[mm] [mm] [mm]
DRF41mm 0.51 0.79 0.41
SASB41mm 0.46 0.71 0.41
DRF91mm 1.25 2.29 0.64
SASB91mm 1.69 1.54 0.56
The technical performance were supported with an in-vivo
scan of a healthy volunteer, see Fig. 8. It was then concluded
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shown using a black line and SASB using a dashed black line. The top graphs
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Fig. 8. Illustration of first in-vivo scan displaying the liver and tip of right
kidney, (left) SASB and (right) Dynamic Receive Focusing.
that the method was ready for phase II. Parameters were locked
and intensity measurements were performed. Hemmsen et al.
[51] presents details of the study and its technical analysis.
B. Phase II
In phase I the parameters and feasibility of the new method
for abdominal imaging was investigated in a collaboration
between developer and clinical specialists. In this phase, the
developer no longer participate in the study and all acquisition
and processing are performed by trained medical doctors. A
study protocol was developed and approval from the local
ethics committee was obtained. Initially 3 patients with ma-
lignant focal liver lesions (confirmed by biopsy or computed
tomography/magnetic resonance) were included in the study.
The patients were scanned in three positions, where the liver
lesions were visible and in three areas where no pathology
was visible. Data from the conventional technique and the new
techniques, respectively dynamic receive focusing and SASB,
were acquired simultaneously, giving images from the same
anatomical location.
Using the described methodology for assessment of diag-
nostic accuracy and diagnostic thinking, two medical doctors
(ultrasound specialists) evaluated the image sequences. None
of the two were involved in the project, nor had they any
prior knowledge about the details of SASB imaging, or seen
any of the images beforehand. Evaluations were done blinded
and independently of each other. Each sequence pair was first
displayed two times with opposite left-right placement for
assessment of diagnostic thinking efficacy. The sequence pairs
were then split and the individual sequences were displayed
for assessment of diagnostic accuracy. This gave 48 + 48
presentations of the 24 sequence pairs. Before the assessment
the assessors were introduced to the rating program and
instructed how to interpret the scales when performing the
assessments. Labels on the scales were hidden during the
actual evaluation to avoid categorized data. Before the actual
assessment, five trial examples were shown to get the assessors
acquainted with the task at hand and which types of images
to expect.
Three medical doctors assessed the acquired stimuli and
statistical analysis was performed. Fig. 9 illustrates the distri-
bution of scores from the assessments of diagnostic-thinking
efficacy. The details of the study and the statistical analysis,
is presented in [52].
(a) (b)
Fig. 9. Histograms from the assessment of diagnostic thinking. (a) assessor
1, (b) assessor 2. (From [52])
C. Phase III
Based on the statistical analysis from phase II forty-
three patients with different kinds of malignant focal liver
cancer (primary liver tumor or liver metastasis) were asked
to participate in the study. All patients were included after
providing informed consent and on approval by the Danish
National Committee on Biomedical Research Ethics (Journal
No. H-1-2011-124). Before the study, liver lesions were diag-
nosed by biopsy or computed tomography/magnetic resonance
(CT/MR). Before the experimental scan, an orientation scan
was performed with a conventional ultrasound scanner (Ultra-
View 800, BK Medical, Herlev, Denmark). Included were only
patients in whom the pathology was visible on the orientation
scan. Twelve patients were excluded because the pathology
was not visible; thus, a total of 31 patients with focal liver
cancer (28 colorectal liver metastases and 3 hepatocellular
carcinomas) were examined with the experimental setup.
The patients were scanned in three positions, where the liver
lesions were visible, and in three areas where no pathology
was visible. The patients were positioned supine and were
told to hold their breath and lie still during recording. The
aim was to record six sequences for each patient, but because
of technical challenges, this was possible for only 28 patients.
One patient had only three recordings, and two patients had
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seven recordings because of errors made while saving and
noticed after the scan session. A total of 185 image sequences
were recorded. The recorded data were processed off-line
with no user interaction. To ensure that clinically valuable
image sequences were generated, a subsequent selection was
performed before the assessments. Images defined as not
clinically valuable were (i) sequences in which no liver tissue
was visible, (ii) sequences in which malignant focal liver
cancer was not visible even though it had been reported
and (iii) sequences in which patient movement made the
sequence impossible to assess. The selection was done blinded
to knowledge of image technique.
Using the described methodology for assessment of
diagnostic-accuracy and diagnostic-thinking, eight radiologists
blinded to the methods assessed all image sequences. Each
sequence pair was first displayed two times with opposite
left-right placement for assessment of diagnostic thinking
efficacy. The sequence pairs were then split and the individ-
ual sequences were displayed for assessment of diagnostic
accuracy. This gave 254 + 254 presentations of the 127
sequence pairs. In total, 4,064 assessments were completed.
The average duration to assess one set of image sequences
was approximately one hour, i.e. 15 seconds on average per
image sequence. The details of the study and the statistical
analysis is presented in [26].
The ROC assessment was not conducted in [26], but the
same data has been used by one medical doctor (AHB) to
perform the assessment as an example, and the result is
shown in Fig. 10. All images were reviewed and graded on
a scale from 0 to 100 indicating the confidence of seeing
a tumor in the image with 100 being absolute certainty.
The results have then been converted into the ROC curve
shown in Fig. 10. The area under the curve shows a slight
advantage for SASB-THI compared to traditional non-linear
imaging. This difference does not yield a clear clinical benefit
of SASB, but it demonstrates that SASB images are similar
in performance to traditional ultrasound images although a
data reduction of a factor of 64 is attained by SASB. This
demonstrates the possibility of introducing wireless probes
without compromising image quality.
Fig. 10. Result of the diagnostic accuracy assessment for a single doctor.
VII. DISCUSSION AND CONCLUSION
Based on the general six-tiered hierarchical model by Fry-
back and Thornbury, a three phased methodology for assessing
the quality of new imaging methods has been presented and
demonstrated. The three phases of the methodology describes
an assessment of competing methods from basic laws of
physics, through clinical use in decisions about diagnosis.
Recommendations to the clinical assessment protocol, soft-
ware, and statistical analysis are presented. Earlier uses of the
methodology on linear and non-linear imaging using SA and
SASB has shown that the methodology gives valid assess-
ments [24]–[26], as it separates the developer, investigator,
and assessor once a research protocol has been established.
This separation eliminates confounding influence on the result
from the developer, as the successful introduction of new
ultrasound imaging methods is driven by their clinical value.
The methodology was exemplified using recent studies of
Synthetic Aperture Sequential Beamforming tissue harmonic
imaging, and its development was based on a number of
studies conducted by our group.
The developed framework is a starting point for designing
clinical studies for comparing two imaging methods as it
forces a structure on the process and exemplifies the decisions
on how to conduct the study. The first stage ensures the
completion of the method in that all choices have to be taken
before it can be implemented in a commercial scanner. It
should not be possible to change and tweak parameters during
the clinical study, as this is not a realistic option in a real
clinical setting. Some parameters should be changeable by
the radiologist, but often it is difficult in an experimental
set-up in real-time to have all options available as the final
processing is not real-time. In many studies data collection
must be separated from the final processing as the demands in
e.g. SA imaging [24], minimum variance beamforming, or 3-
D imaging are too demanding for a real time implementation.
This can have a biasing effect, as the real time orientation
image does not reveal the same details as the improved
approach, and therefore the scan angles would be different.
It is, thus, important that the radiologist performing scans is
experienced to choose the right views. In this process there
might also be limiting factors in having two imaging sequences
being emitted inter-spaced. This will often reduce the frame
rate by a factor of two [25] and it can also limit the energy
possible to emit. Having a poor orientation image during
data acquisition can also lead to poor image views, and such
images should be removed from the evaluation, as they have
no clinical values. The person removing these images should
not be part of the evaluation, and the object criteria for removal
should be clarified.
The evaluation is performed either by finding features in a
single image or comparing two images side by side. Blinding
and randomizing the evaluation takes care of many biasing
effects, but there are still cases where tradition or other effect
might be limiting. For new imaging methods like minimum
variance [7], [53] or spatial coherence [54], [55] the images
might appear radically different than conventional ultrasound
images, and this will in general bias the evaluation towards
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the conventional image and preclude new inventions. This is
a general problem in a necessarily conservative field. Clinical
significance as described in [56] is a metric similar to the
ROC curve, but it can be more appropriate when studies report
efficacy in terms of a continuous measurement. The evaluation
can also be dependent on the experience of the evaluator, and
this can be separated out in the statistical processing, or all
evaluations can be polled to reflect the diversity of radiologist
using ultrasound.
A vital point in any comparison is the reference image. It
can be problematic to have the developer of new algorithms
also optimize the reference method, as there is an inherent
bias towards the new method. The best approach is therefore
to have an independent reference in the form of a commercial
image separately optimized. A further problem with commer-
cial images if often the heavy post-processing intended to
improve image quality and remove artifacts. This is a very
important part of modern ultrasound imaging, but obscures
the real benefit of new acquisition schemes. Two approach
can reduce these effects: The processing can be disabled on
both images. This ensures a fair comparison of the basic image
acquisition and processing. The drawback is the ”raw” image
quality, which often is unusual for the evaluators to judge. The
second approach is to enable post-processing on both images.
This has the drawback that the processing is optimized for
the conventional image and not for the new image like phase
coherence [54]. We have used the first approach of disabling
post-processing in the studies we currently have conducted,
and have often been confronted with the rather poor image
quality of ”raw” images by the evaluators.
This also touches on the learning aspect of the evaluation.
What should the assessor expect and how should the relative
VAS scale be used? The selection of the training set and the
presentation of this is difficult, as it affects the outcome, and
it is a constant discussion during the planning of a study on
how to select and present the training set, what questions to
ask, and how to instruct evaluators [26].
There is no doubt that making an evaluation of new imaging
methods is complicated and affected by many factors. The
mere method of presenting a few random examples and inter-
pret them by scientists involved in the research is insufficient.
This paper have presented our ideas and thoughts about how to
evaluate methods in a less biased and more quantitative way. It
will not work for every situation, but it hopefully spurs some
thoughts and discussion and forward the field of improving
ultrasound imaging by introducing new methods valuable in
the clinic.
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